Seroprevalence Of Cytomegalovirus Among Hemodialysis Patients In Misurata City-Libya
Article Sidebar
Main Article Content
Abstract
Cytomegalovirus (CMV) belongs to the herpes virus family, it has the ability to cause systemic infection and serious diseases in immunocompromised patients such as hemodialysis patients. The aim of this study was to investigate the prevalence of CMV infection among hemodialysis (HD) patients. One hundred and seventy (170) of HD patients (95 males & 75 females) attending the Misurata center for nephrology and dialysis were included in this cross-sectional study, thirty (30) of apparently healthy individuals (13 male & 17 female) were also employed as a control group. Detection of CMV-IgM & CMV-IgG antibodies in serum samples was carried out by Enzyme-Linked Immunosorbent Assay technique. Results showed that CMV-IgM antibodies were detected in 29/200 (14.5%) of the total study population, whereas 21/170 (12.4%) of hemodialysis patients and 8/30 (26.7%) of control subjects were seropositive for CMV IgM antibodies; in addition 186/200 (93%) of the total study population were seropositive for CMV-IgG antibodies, in which 162/170 (95.3%) of HD patients and 24/30 (80%) of the control group were seropositive for CMV IgG antibodies; the seroprevalence of CMV-IgM antibodies was significantly correlated with the frequency of hemodialysis/week, kidney transplantation, blood transfusion, surgical operations, and therapeutic drugs (P= 0.035, 0.039, 0.041, 0.000, and 0.004 respectively); however, seroprevalence of CMV-IgG antibodies was significantly associated with duration of ESRD & HD, and frequency of hemodialysis/week (P= 0.019, 0.020 respectively). In conclusion, results showed a high prevalence of CMV infection among the study population, which could be related to duration of ESRD & HD, blood transfusion, frequency of hemodialysis/week, surgical operations, therapeutic drugs.
Downloads
Article Details
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the Sebha University, where authors who have published their articles in the Sebha University journal can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
- Privacy Statement The names and e-mail addresses entered on the Sebha University Journal site will be used for the aforementioned purposes only and for which they were used.
